ABBV
AbbVie Inc. · Healthcare · Market cap $463.9B
Insiders sold $8.2M net in the last 90 days ·1 seller, 0 buyers· latest Form 4 filed Aug 18, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$18.9M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Latest filing
Aug 18, 2026
Donoghoe Nicholas
AbbVie Inc. (ABBV) has 33 SEC Form 4 filings (65 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Aug 18, 2026.
Inside the rolling window, 3 insiders at AbbVie Inc. reported no open-market purchases and 4 open-market sales totaling $18.9M. Insiders have net sold $18.9M over the trailing 6 months. The most recent open-market filing is a sale of 32,710 shares by EVP, CHIEF BUS/STRAT OFFICER Donoghoe Nicholas, dated Aug 14, 2026, worth $8.2M.
- Industry:Drug Manufacturers - General
- CEO:Robert A. Michael
- Employees:57,000
- HQ:North Chicago, IL, US
- IPO:2013-01-02
| Source | |||||||
|---|---|---|---|---|---|---|---|
Donoghoe NicholasFirst filing | EVP, CHIEF BUS/STRAT OFFICER | Sale | 32,710 | $8.2M | Aug 18 | +1.4% | SEC ↗ |
Purdue David RyanFirst filing | SVP, Controller | Sale | 5,230 | $1.2M | Mar 6 | +14.1% | SEC ↗ |
| EVP, GC AND SECRETARY | Sale | 18,668 | $4.4M | Mar 3 | +12.3% | SEC ↗ | |
Siatis Perry CFirst filing | EVP, GC AND SECRETARY | Sale | 22,381 | $5.1M | Feb 27 | +13.1% | SEC ↗ |
Earnings: last 7 quarters
Congress trading ABBV 198 all-time
- DRep. Ro KhannaPurchase$15,001 - $50,0002026-05-01
- DRep. Ro KhannaPurchase$15,001 - $50,0002026-05-01
- DRep. Josh GottheimerSale$1,001 - $15,0002026-05-05
- DRep. Josh S. GottheimerSale$1,001 - $15,0002026-05-05
- DRep. Ro KhannaSale$15,001 - $50,0002026-01-29
- DRep. Julie JohnsonSale$1,001 - $15,0002025-12-18
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does ABBV have?
AbbVie Inc. (ABBV) has 33 SEC Form 4 filings (65 transaction rows) in the rolling 365-day window, disclosed by 3 distinct insiders. Most recent filing: Aug 18, 2026.
When was the most recent SEC Form 4 filing for ABBV?
The most recent Form 4 filing for ABBV on Tracefour is dated Aug 18, 2026.
What is the net insider flow at ABBV over the last 6 months?
Over the trailing 180 days, insiders at ABBV have net sold $18.9M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at ABBV in the current window?
Inside the rolling window, insiders at ABBV bought $0 and sold $18.9M based on SEC Form 4 filings.
Can I get alerts for ABBV insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at AbbVie Inc. (ABBV). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
AbbVie Inc. is in the Healthcare sector.